SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-15-002064
Filing Date
2015-05-20
Accepted
2015-05-20 17:26:17
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT xenetic_10q-033115.htm 10-Q 283113
2 CERTIFICATION xenetic_10q-ex3101.htm EX-31.1 8295
3 CERTIFICATION xenetic_10q-ex3102.htm EX-31.2 8271
4 CERTIFICATION xenetic_10q-ex3201.htm EX-32.1 3277
  Complete submission text file 0001019687-15-002064.txt   1964320

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE xbio-20150331.xml EX-101.INS 160007
6 XBRL SCHEMA FILE xbio-20150331.xsd EX-101.SCH 23124
7 XBRL CALCULATION FILE xbio-20150331_cal.xml EX-101.CAL 40459
8 XBRL DEFINITION FILE xbio-20150331_def.xml EX-101.DEF 48780
9 XBRL LABEL FILE xbio-20150331_lab.xml EX-101.LAB 175059
10 XBRL PRESENTATION FILE xbio-20150331_pre.xml EX-101.PRE 125302
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-178082 | Film No.: 15880560
SIC: 2834 Pharmaceutical Preparations